Cytek Biosciences, Inc.'s (CTKB) CEO Wenbin Jiang on Q4 2021 Results - Earnings Call Transcript

Feb. 23, 2022 8:52 PM ETCytek Biosciences, Inc. (CTKB)
SA Transcripts profile picture
SA Transcripts

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET

Company Participants

Alex Khan - Investor Relations

Wenbin Jiang - Chief Executive Officer

Patrik Jeanmonod - Chief Financial Officer

Allen Poirson - Senior Vice President, Marketing and Corporate Development

Conference Call Participants

Tejas Savant - Morgan Stanley

Dave Delahunt - Goldman Sachs

David Westenberg - Piper Sandler


Thank you for standing by. And welcome to the Cytek Biosciences Fourth Quarter 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]

As a reminder, today’s program may be recorded. I would now like to introduce your host for today’s program, Alex Khan, Investor Relations. Please go ahead, sir.

Alex Khan

Thank you. Earlier today Cytek Biosciences released financial results for the quarter and year ended December 31, 20 21. If you haven’t received this news release or if you’d like to be added to the company’s distribution list, please send an email to investors at

Joining me today from Cytek are when Wenbin Jiang, CEO; and Patrik Jeanmonod, Chief Financial Officer.

Before we begin, I’d like to remind you that manager will make statements during this call that are forward-looking statements within the meetings of the federal securities laws, including statements regarding Cytek’s business plans, strategies, opportunities, and financial projections. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.

Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release Cytek issued today and in Cytek’s filings with the SEC.

This call will also include a discussion of certain financial measures that are not calculated in accordance with Generally Accepted Accounting

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.